Cardiac macrophage density in Covid-19 infection: relationship to myocyte necrosis and acute lung injury

Husam Jum'ah1, Sirisha Kundrapu1, Ahmad Jabri2

  • 1Department of Pathology, MetroHealth Medical Center, Cleveland, OH, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Insights

COVID-19 autopsies reveal increased single myocyte necrosis and higher macrophage density in the heart, suggesting macrophages play a key role in SARS-CoV-2 cardiac pathology beyond lung injury strain.

Area of Science:

  • Pathology
  • Immunology
  • Cardiology

Background:

  • SARS-CoV-2 infection affects multiple organs, including the heart, with cardiac involvement linked to higher mortality.
  • The specific myocardial pathological changes and immune cell roles in fatal COVID-19 cases remain uncertain.
  • Macrophages are integral immune cells within the normal heart.

Purpose of the Study:

  • To compare cardiac findings in COVID-19 decedents versus controls with non-SARS-CoV-2 pneumonia.
  • To investigate single myocyte necrosis and its relation to lung injury strain.
  • To quantify myocardial and epicardial macrophage density in COVID-19 hearts.

Main Methods:

  • Case-control autopsy study comparing 10 COVID-19 decedents with 20 controls.
  • Semi-quantitative analysis of gross and microscopic cardiac findings.
  • Assessment of single myocyte necrosis and macrophage density (myocardium, epicardium).

Main Results:

  • No lymphocytic myocarditis was observed in either group.
  • Single myocyte necrosis was more frequent in COVID-19 hearts, independent of lung injury strain.
  • Increased myocardial and epicardial macrophage density was found in COVID-19 hearts compared to controls.
  • Epicardial macrophage density was higher in COVID-19 hearts with myocyte necrosis.

Conclusions:

  • Single myocyte necrosis is a feature of fatal SARS-CoV-2 infection.
  • Macrophages are implicated in the cardiac pathophysiology of COVID-19.
  • Macrophage accumulation in the heart may contribute to adverse cardiac outcomes in COVID-19.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32
Inflammation01:38

Inflammation

Overview
55.0K